CVS HEALTH Corp Quarterly Income Tax Expense (Benefit) in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
CVS HEALTH Corp quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2010 to Q3 2024.
  • CVS HEALTH Corp Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $34M, a 95.5% decline year-over-year.
  • CVS HEALTH Corp Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $1.72B, a 42.1% decline year-over-year.
  • CVS HEALTH Corp annual Income Tax Expense (Benefit) for 2023 was $2.81B, a 85.9% increase from 2022.
  • CVS HEALTH Corp annual Income Tax Expense (Benefit) for 2022 was $1.51B, a 40.8% decline from 2021.
  • CVS HEALTH Corp annual Income Tax Expense (Benefit) for 2021 was $2.55B, a 0.82% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $1.72B $34M -$720M -95.5% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $2.44B $569M -$87M -13.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $2.52B $456M -$281M -38.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $2.81B $658M -$160M -19.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-07
Q3 2023 $2.97B $754M +$1.8B Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 $1.17B $656M -$434M -39.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $1.6B $737M +$91M +14.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-01
Q4 2022 $1.51B $818M +$518M +173% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-07
Q3 2022 $991M -$1.05B -$1.6B -287% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 $2.59B $1.09B +$146M +15.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 $2.45B $646M -$100M -13.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 $2.55B $300M +$59M +24.5% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-07
Q3 2021 $2.49B $558M -$29M -4.94% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 $2.52B $944M -$30M -3.08% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $2.55B $746M -$21M -2.74% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $2.57B $241M -$349M -59.2% Oct 1, 2020 Dec 31, 2020 8-K 2023-05-25
Q3 2020 $2.92B $587M -$17M -2.82% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $2.94B $974M +$314M +47.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 $2.62B $767M +$255M +49.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 $2.37B $590M +$66M +12.6% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-09
Q3 2019 $2.3B $604M +$95M +18.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $2.21B $660M +$163M +32.8% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 $2.04B $512M +$40M +8.48% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 $2B $524M +$1B Oct 1, 2018 Dec 31, 2018 10-K 2021-02-16
Q3 2018 $1B $509M -$268M -34.5% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 $1.27B $497M -$269M -35.1% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 $1.54B $472M -$100M -17.5% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-01
Q4 2017 $1.64B -$478M -$1.52B -146% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-18
Q3 2017 $3.16B $777M -$144M -15.6% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 $3.31B $766M +$162M +26.8% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 $3.14B $572M -$174M -23.3% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-02
Q4 2016 $3.32B $1.05B +$94M +9.87% Oct 1, 2016 Dec 31, 2016 8-K 2019-08-08
Q3 2016 $3.22B $921M +$88M +10.6% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-06
Q2 2016 $3.14B $604M -$220M -26.7% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 $3.36B $746M -$31M -3.99% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-02
Q4 2015 $3.39B $952M +$84M +9.68% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-14
Q3 2015 $3.3B $833M +$209M +33.5% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-08
Q2 2015 $3.09B $824M +$20M +2.49% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-02
Q1 2015 $3.07B $777M +$40M +5.43% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-03
Q4 2014 $3.03B $868M +$52M +6.37% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-09
Q3 2014 $2.98B $624M -$153M -19.7% Jul 1, 2014 Sep 30, 2014 10-Q 2015-10-30
Q2 2014 $3.13B $804M +$83M +11.5% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-04
Q1 2014 $3.05B $737M +$123M +20% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-01
Q4 2013 $2.93B $816M +$155M +23.4% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-09
Q3 2013 $2.77B $777M +$108M +16.1% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-04
Q2 2013 $2.67B $721M +$111M +18.2% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-05
Q1 2013 $2.55B $614M +$118M +23.8% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-02
Q4 2012 $2.44B $661M -$50M -7.03% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-10
Q3 2012 $2.49B $669M +$107M +19% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-05
Q2 2012 $2.38B $610M +$87M +16.6% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-06
Q1 2012 $2.29B $496M +$34M +7.36% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-01
Q4 2011 $2.26B $711M +$112M +18.7% Oct 1, 2011 Dec 31, 2011 10-K 2014-02-11
Q3 2011 $2.15B $562M +$36M +6.84% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-06
Q2 2011 $2.11B $523M -$21M -3.86% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-07
Q1 2011 $2.13B $462M -$48M -9.41% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-02
Q4 2010 $2.18B $599M Oct 1, 2010 Dec 31, 2010 10-K 2013-02-15
Q3 2010 $526M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-03
Q2 2010 $544M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-04
Q1 2010 $510M Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.